Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer-Reference-Cited by-同舟云学术

Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer

Published:2015-08-13 Issue:4 Volume:34 Page:509-515
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Kaufmann S.,Bedke J.^ORCID,Gatidis S.,Hennenlotter J.,Kramer U.,Notohamiprodjo M.,Nikolaou K.,Stenzl A.,Kruck S.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-015-1655-8.pdf

Reference30 articles.

1. Roethke M, Anastasiadis AG, Lichy M, Werner M, Wagner P, Kruck S, Claussen CD, Stenzl A, Schlemmer HP, Schilling D (2012) MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 30(2):213–218. doi: 10.1007/s00345-011-0675-2

2. Jeong CW, Ku JH, Moon KC, Hong SK, Byun SS, Cho JY, Kim HH, Kim SH, Lee SE, Kwak C (2012) Can conventional magnetic resonance imaging, prostate needle biopsy, or their combination predict the laterality of clinically localized prostate cancer? Urology 79(6):1322–1327. doi: 10.1016/j.urology.2012.01.080

3. van Hove A, Savoie PH, Maurin C, Brunelle S, Gravis G, Salem N, Walz J (2014) Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies. World J Urol 32(4):847–858. doi: 10.1007/s00345-014-1332-3

4. Colleselli D, Schilling D, Lichy MP, Hennenlotter J, Vogel UH, Krueger SA, Kuehs U, Schlemmer HP, Stenzl A, Schwentner C (2010) Topographical sensitivity and specificity of endorectal coil magnetic resonance imaging for prostate cancer detection. Urol Int 84(4):388–394. doi: 10.1159/000300572

5. Anastasiadis AG, Lichy MP, Nagele U, Kuczyk MA, Merseburger AS, Hennenlotter J, Corvin S, Sievert KD, Claussen CD, Stenzl A, Schlemmer HP (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50(4):738–748. doi: 10.1016/j.eururo.2006.03.007 (discussion 748–739)

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Approach to Prostate Imaging and Data Reporting System Score 3 Lesions;Radiologic Clinics of North America;2024-01

2. Recent trends in the delivery of plant-derived phytochemicals against various cancers using Nanotechnological approach: A comprehensive review;Journal of Drug Delivery Science and Technology;2023-09

3. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy;World Journal of Urology;2022-08-04

4. Lesion Volume in a Bi- or Multivariate Prediction Model for the Management of PI-RADS v2.1 Score 3 Category Lesions;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-07-28

5. T2 mapping for the characterization of prostate lesions;World Journal of Urology;2022-03-31